>> Signaling Pathways >> Apoptosis >> c-RET

c-RET

The c-RET proto-oncogene, which was originally identified as a transforming gene by transfection of T-cell lymphoma DNA into NIH3T3 cells, is a member of the receptor tyrosine kinase (RTK) gene superfamily that encodes a receptor tyrosine kinase involved in the regulation of glial cell line-derived neurotrophic factor (GDNF) signaling. Signaling proteins, such as Grb7/Grb10, PLCγ, Shc/Enigma and Grb2, are recruited by activated c-RET protein through binding to the phosphorylated tyrosine residues in c-RET protein’s COOH-terminal sequence, Y905, Y1015, Y1062 and Y1096 respectively.  Moreover, results of in vivo studies suggest mutations of c-RET have been implicated in tumorigenesis, in which c-RET mRNA and/or protein have been found in tumors of neuroectodermal origin as well as in human neuroblastoma cell lines.

Products for  c-RET

  1. Cat.No. 상품명 정보
  2. GC16362 AD57 (hydrochloride) polypharmacological cancer therapeutic that inhibits RET. AD57 (hydrochloride)  Chemical Structure
  3. GC16391 Amuvatinib (MP-470, HPK 56) A multi-targeted RTK inhibitor Amuvatinib (MP-470, HPK 56)  Chemical Structure
  4. GC15217 Danusertib (PHA-739358) A pan-Aurora kinase and Abl inhibitor Danusertib (PHA-739358)  Chemical Structure
  5. GC14606 Regorafenib hydrochloride A multi-kinase inhibitor Regorafenib hydrochloride  Chemical Structure
  6. GC14534 Regorafenib monohydrate A multi-kinase inhibitor Regorafenib monohydrate  Chemical Structure
  7. GC13194 RPI-1 RPI-1은 경구로 사용할 수 있는 특정 2-인돌리논 Ret 티로신 키나제 억제제입니다. RPI-1은 인간 수질 갑상선 암종 TT 세포에서 증식, Ret 티로신 인산화, Ret 단백질 발현 및 PLC감마, ERK 및 AKT의 활성화를 억제합니다. 항종양 활성. RPI-1  Chemical Structure
  8. GC15307 SU5416

    A tyrosine kinase inhibitor

    SU5416  Chemical Structure
  9. GC10035 TG101209 An inhibitor of JAK2, FLT3, RET, and JAK3 TG101209  Chemical Structure

8 Item(s)

페이지 당

내림차순